Education
About Us
Working with TipRanks
Follow Us
Tilray (TSE:TLRY)
TSX:TLRY
TLRY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.49 - C$2.97
Previous CloseN/A
Volume1.39M
Average Volume (3M)2.17M
Market Cap
$859.52M
Enterprise ValueC$759.87M
Total Cash (Recent Filing)$248.41M
Total Debt (Recent Filing)$343.91M
Price to Earnings (P/E)―
Beta1.92
Next Earnings
Jul 28, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.19
Shares Outstanding1,038,122,300
10 Day Avg. Volume2,026,794
30 Day Avg. Volume2,168,904
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.00
P/FCF Ratio-7.57
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit3.22
Enterprise Value/Ebitda-0.83
Forecast
1Y Price Target
$0.89Price Target Upside7.29% Upside
Rating ConsensusHold
Number of Analyst Covering0
Tilray News
Bulls Say, Bears Say
Bulls Say
Cost SavingsBeverage Improvement Plans are back on track with internalized production and focus on core markets, resulting in significant cost savings.
Financial PerformanceAdj. EBITDA of $9M came in higher than expected, supported by better-than-expected Canadian cannabis gross margins of 40.5%.
Future OutlookManagement anticipates stronger performance in the fourth fiscal quarter due to seasonal growth in acquired brands.
Bears Say
Market ChallengesThe craft beer category and Canadian cannabis markets are under competitive pressure, affecting Tilray's outlook.
Regulatory EnvironmentThe path to federal legalization of cannabis in the U.S. remains unclear, impacting future prospects.
Sales OutlookManagement lowered their FY25 sales outlook by $50M to $850M-$900M due to SKU rationalization efforts.
Options Prices
Currently, No data available
---
Ownership Overview
0.64% Insiders
0.39%
Mutual Funds
1.34% Other Institutional Investors
96.48% Public Companies and Individual Investors
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was C$0.48 and its highest was C$2.97 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $859.52M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 28, 2025 which is in 9 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 08, 2025. The company reported -C$1.195 earnings per share for the quarter, missing the consensus estimate of -C$0.052 by -C$1.143.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.03.
How many shares outstanding does Tilray have?
Tilray has 1,038,122,300 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -C$1.195 in its last earnings report, missing expectations of -C$0.052. Following the earnings report the stock price went down -20.988%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TSE:TLRY
Tilray Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.89 (7.29% Upside)
$0.89 (7.29% Upside)
Blogger Sentiment
Neutral
TSE:TLRY Sentiment 50%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Negative
Last 7 Days ▲ 1.4%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.84%
12-Months-Change
Fundamentals
Return on Equity
-31.06%
Trailing 12-Months
Asset Growth
-19.22%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented both positive and negative aspects. While there were notable improvements in cannabis gross margins and international growth, significant challenges remain, particularly with net revenue decline and a substantial net loss due to non-cash impairment. The beverage segment showed mixed results with some areas of growth, but overall sales volumes faced challenges.Read More>